| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/09/2013 | CN102863528A Bovine-derived anti-staphylococcus aureus single-chain antibody, preparation method and application thereof |
| 01/09/2013 | CN102863515A B-cell epitope of human melanoma antigen MAGE-A3 and application thereof |
| 01/09/2013 | CN102080101B Targeted exogenous gene integration method |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101787078B Collagen polypeptide, preparation method and application thereof |
| 01/08/2013 | US8350020 Compositions and methods related to mRNA translational enhancer elements |
| 01/08/2013 | US8350019 Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 01/08/2013 | US8350009 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; biomarkers |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349601 Trichoderma reesei glucoamylase and homologs thereof |
| 01/08/2013 | US8349599 Multimeric oxidoreductases |
| 01/08/2013 | US8349589 Non-natural recombinant gelatins with enhanced functionality |
| 01/08/2013 | US8349588 Recombinant XRGD-enriched gelatins having high stability |
| 01/08/2013 | US8349586 Commensal strain of E. coli encoding an HIV GP41 protein |
| 01/08/2013 | US8349578 Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids |
| 01/08/2013 | US8349336 Streptococcus pyogenes antigens |
| 01/08/2013 | US8349333 Allergy inhibitor compositions and kits and methods of using the same |
| 01/08/2013 | US8349332 Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases |
| 01/08/2013 | US8349331 Anti-interferon-α antibodies |
| 01/08/2013 | US8349326 Methods and systems for multi-antibody therapies |
| 01/08/2013 | US8349318 Use of specifically engineered enzymes to enhance the efficacy of prodrugs |
| 01/08/2013 | US8349311 Mutant interleukin-2 (IL-2) polypeptides |
| 01/08/2013 | CA2672126C A novel method to isolate mutants and to clone the complementing gene |
| 01/08/2013 | CA2642539C Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 01/08/2013 | CA2629643C Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
| 01/08/2013 | CA2578141C Production of polypeptides |
| 01/08/2013 | CA2542576C Transgenic organisms with lower growth temperature |
| 01/08/2013 | CA2506527C Bgl7 beta-glucosidase and nucleic acids encoding the same |
| 01/08/2013 | CA2496437C Improved methods of in vitro protein synthesis |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2457541C Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 01/08/2013 | CA2454361C Humanized antibodies |
| 01/08/2013 | CA2341777C Neutral amino acid transporter and gene thereof |
| 01/08/2013 | CA2299630C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/08/2013 | CA2286090C Forms of prostate specific antigen and methods for their detection |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/03/2013 | WO2013003767A2 Cells deficient in cmp-n-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase |
| 01/03/2013 | WO2013003555A1 Using sortases to install click chemistry handles for protein ligation |
| 01/03/2013 | WO2012140676A9 Chimeric antibacterial polypeptides |
| 01/03/2013 | WO2012069593A3 Fusion enzymes having n-acetylglucosaminyltransferase activity |
| 01/03/2013 | US20130005951 Process for preparing fgf21 with low degree of o-glycosylation |
| 01/03/2013 | US20130005949 Antibodies against human csf-1r and uses thereof |
| 01/03/2013 | US20130005667 Heterologous expression of neisserial proteins |
| 01/03/2013 | US20130005642 Methods for recovering peptides/amino acids and oil/fat from one or more protein-containing raw materials, and products produced by the methods |
| 01/03/2013 | US20130004993 Green Chemical Process to Produce Natural Products |
| 01/03/2013 | US20130004992 Cells deficient in cmp-n-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase |
| 01/03/2013 | US20130004991 Positive cytomodulines to improve bioreactor productivity |
| 01/03/2013 | US20130004979 Glycosyltransferase reversibility for sugar nucleotide synthesis and microscale scanning |
| 01/03/2013 | US20130004961 Methods of detecting a sweet-sensitive cell |
| 01/03/2013 | US20130004530 Vaccine composition |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004510 Vaccine |
| 01/03/2013 | US20130004501 Human il-23 antigen binding proteins |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2840409A1 Using sortases to install click chemistry handles for protein ligation |
| 01/02/2013 | EP2540820A1 Means and methods for influencing the stability of antibody producing cells |
| 01/02/2013 | EP2540741A1 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1671416B Super humanized antibodies |
| 01/02/2013 | CN102859001A Method for the selection of a long-term producing cell |
| 01/02/2013 | CN102858981A High level expression of recombinant CRM197 |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858977A Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858976A Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858975A Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858974A Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858958A Induced Hepatic Stem Cell And Process For Production Thereof, And Applications Of The Cell |
| 01/02/2013 | CN102858799A Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102851346A Preparation method of fish bone collagen polypeptide with anti-prostate cancer function |
| 01/02/2013 | CN102851345A Preparation method for chlorella antitumor polypeptide |
| 01/02/2013 | CN102851344A Preparation method for spirulina antitumor polypeptide |
| 01/02/2013 | CN102851343A Preparation method for chlorella antitumor polypeptide |
| 01/02/2013 | CN102851342A Preparation method of egg white peptide |
| 01/02/2013 | CN102851341A Process for preparing collagen polypeptides through hydrolyzing codfish skins by double-enzyme composite method |
| 01/02/2013 | CN102851340A Preparation method for efficient chicken gene engineering chicken interferon alpha |
| 01/02/2013 | CN102851339A Production method of Sublancin antibacterial peptide |
| 01/02/2013 | CN102851338A Method for preparing homodimer protein mixture by using charge repulsive interaction |
| 01/02/2013 | CN102851313A Hepatitis b vaccine and preparation technology thereof |
| 01/02/2013 | CN102851272A Gamma-glutamyltranspeptidase immobilized enzyme, preparation method and application thereof |
| 01/02/2013 | CN102851242A BaciLLus subtiLis, culture method and applications thereof |
| 01/02/2013 | CN102850458A Novel recombined dual-function fusion protein and its preparation method and application |
| 01/02/2013 | CN102850456A Humanized monoclonal antibody of vascular endothelial growth factor as well as preparation method and application thereof |
| 01/02/2013 | CN102850455A Anti-glypican-3 antibody |
| 01/02/2013 | CN102850430A Animal colostrum derived protein fragment and application thereof |
| 01/02/2013 | CN102847134A Preparation method for chlorella polypeptide microcapsule |
| 01/02/2013 | CN102846553A Preparation method for chlorella polypeptide-chitosan nanoparticle |
| 01/02/2013 | CN102220345B Recombinant canine alpha-interferon optimized gene, strain and efficient expression |
| 01/02/2013 | CN102212107B Rice protein polypeptide and preparation method thereof |
| 01/02/2013 | CN101979649B Method for controlling Pichia pastoris to ferment to produce antibacterial peptide by utilizing dissolved oxygen parameters |
| 01/02/2013 | CN101974451B PopW antibacterial protein and pseudomonas fluorescens mixed biological preparation PopW-PF1 |
| 01/02/2013 | CN101942496B Method for preparing virus analogs of nervous necrosis viruses |
| 01/02/2013 | CN101799476B Reagent box for sieving autoantibody for tsh receptor |
| 01/02/2013 | CN101792680B Comprehensive utilization method and system for coal |
| 01/02/2013 | CN101426812B Methods for altering protein production rates |
| 01/02/2013 | CN101297789B Methods of producing lignin peroxidase and use thereof in skin and hair lightening |
| 01/02/2013 | CN101103044B Anti-alhpha 9 integrin antibody and the use thereof |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8343767 Methods for increasing homologous recombination of a nucleic acid sequences |